Ventrus-Assembly Merger Brings Novel HBV Technology Public
Insights - Ventrus and Assembly Pharma plan to merge to develop their novel HBV te.chnology
Read NowzFree
FDA Kicks the Can Down the Road for Keryx’s Lead Drug
Insights - The FDA extended the approval decision date for Zerenex (ferric citrate) by 3 months, to September 7, following revisions to Keryx’s new drug application.
Read Now
One Question to Ask When Considering Intercept Pharmaceuticals
Insights - Shares of Intercept Pharmaceuticals (ICPT) dropped early this week when documents attained through an FOIA request were made public, painting a picture of a management … Continue Reading
Read NowThe Market Makes All-Time Highs While Biotech Continues the Malaise
Insights - Before we get into the event of the week – the ASCO abstract drop on Wednesday evening – lets take a look at what’s been … Continue Reading
Read Now
Following Up on the ASCO Data Dump
Research - Abstracts from the upcoming American Society of Clinical Oncology (ASCO) annual meeting are out, published on Wednesday evening. The totality of data present in the abstracts isn’t … Continue Reading
Read Now
Sarepta: Big Plans for the Second Half
Research - Sarepta (SRPT) will file a NDA and get 5 new trials off the ground in the next 7 months.
Read NowA Roundup our Top Stories from the Week
Insights - PropThink published an ASCO 2014 preview early this week, highlighting events that will capture Wall Street’s interest as abstracts are published online and presentations kick off at … Continue Reading
Read Now